OB
Olivia Brayer Cantor Fitzgerald Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
VRNA
1
Verona Pharma
VRNA
$9.19B
| $106.30 | $100 |
6%
downside
| Overweight |
11 Jun ‘25
3 months ago |
|
2
United Therapeutics
UTHR
$17.8B
| $403.80 | $405 |
0%
upside
| Overweight |
2 Jun ‘25
3 months ago |
|
3
Vanda Pharmaceuticals
VNDA
$269M
| $4.51 | $13 |
188%
upside
| Overweight |
14 May ‘25
3 months ago |
|
4
BioMarin Pharmaceuticals
BMRN
$10.8B
| $55.69 | $90 |
62%
upside
| Overweight |
20 Feb ‘25
6 months ago |
|
5
Vertex Pharmaceuticals
VRTX
$101B
| $396.48 | $480 |
21%
upside
| Overweight |
11 Feb ‘25
7 months ago |
|
6
Bristol-Myers Squibb
BMY
$95.1B
| $47.23 | $55 |
16%
upside
| Neutral |
4 Feb ‘25
7 months ago |
|
7
Gilead Sciences
GILD
$144B
| $115.76 | $80 |
31%
downside
| Neutral |
11 Dec ‘24
9 months ago |
|
8
Regeneron Pharmaceuticals
REGN
$59.2B
| $556.53 | $1,015 |
82%
upside
| Neutral |
23 Oct ‘24
10 months ago |
|
9
Amgen
AMGN
$151B
| $279.97 | $405 |
45%
upside
| Overweight |
22 Oct ‘24
10 months ago |
|
10
Alnylam Pharmaceuticals
ALNY
$59.6B
| $482.13 | $220 |
54%
downside
| Neutral |
11 Oct ‘24
11 months ago |
|
11
Aurinia Pharmaceuticals
AUPH
$1.62B
| $12.35 | $10 |
19%
downside
| Overweight |
16 Sep ‘24
11 months ago |
|
12
MannKind Corp
MNKD
$1.71B
| $5.51 | $6.50 |
18%
upside
| Overweight |
9 May ‘24
1 year ago |
|
13
CRISPR Therapeutics
CRSP
$4.92B
| $53.69 | $72 |
34%
upside
| Overweight |
13 Apr ‘23
2 years ago |
|
|
LENZ
14
LENZ Therapeutics
LENZ
$1.13B
| $39.89 | $21 |
47%
downside
| Neutral |
23 Feb ‘23
2 years ago |
|